A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors

A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic therapy 2022-09, Vol.35 (9), p.n/a
Hauptverfasser: Huang, Ying, Zhu, Lin, Ma, Xiaoying, Hong, Yiyong, Su, Xiangyang, Lai, Wei, Gong, Zijian
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 9
container_start_page
container_title Dermatologic therapy
container_volume 35
creator Huang, Ying
Zhu, Lin
Ma, Xiaoying
Hong, Yiyong
Su, Xiangyang
Lai, Wei
Gong, Zijian
description
doi_str_mv 10.1111/dth.15663
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_dth_15663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DTH15663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2693-14cee380f7858872a45b4eb225da37f74bdea5152b11d33631031017e7340a343</originalsourceid><addsrcrecordid>eNp1UMlOwzAQtRBIlMKBP_CVQ1ovWblVXSiogkPLOXLsSWuUxJVtqHpDfAHfyJdgCFdGI82i995oHkLXlIxoiLHyuxFN0pSfoAFNWBHlhBanoedFGhFWpOfowrkXQigrOB2gjwmWwgE2NXa687rRrai-3j91p14lKLx-WI8388fbGdhWeNOYrZZYqDewgWRBSK9N57BwzkgtfGActN_hvTVbK9o2zBKaBisQ_daD7oI8xbrb6Up7Y90lOqtF4-Dqrw7R82K-mS6j1dPd_XSyiiRLCx7RWALwnNRZnuR5xkScVDFUjCVK8KzO4iocScLPFaWK85RTEpJmkPGYCB7zIbrpdaU1zlmoy70N39pjSUn5Y14ZzCt_zQvYcY896AaO_wPL2WbZM74BYNN0BA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors</title><source>Wiley Online Library All Journals</source><creator>Huang, Ying ; Zhu, Lin ; Ma, Xiaoying ; Hong, Yiyong ; Su, Xiangyang ; Lai, Wei ; Gong, Zijian</creator><creatorcontrib>Huang, Ying ; Zhu, Lin ; Ma, Xiaoying ; Hong, Yiyong ; Su, Xiangyang ; Lai, Wei ; Gong, Zijian</creatorcontrib><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.15663</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><ispartof>Dermatologic therapy, 2022-09, Vol.35 (9), p.n/a</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2693-14cee380f7858872a45b4eb225da37f74bdea5152b11d33631031017e7340a343</citedby><cites>FETCH-LOGICAL-c2693-14cee380f7858872a45b4eb225da37f74bdea5152b11d33631031017e7340a343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.15663$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.15663$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><creatorcontrib>Ma, Xiaoying</creatorcontrib><creatorcontrib>Hong, Yiyong</creatorcontrib><creatorcontrib>Su, Xiangyang</creatorcontrib><creatorcontrib>Lai, Wei</creatorcontrib><creatorcontrib>Gong, Zijian</creatorcontrib><title>A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors</title><title>Dermatologic therapy</title><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1UMlOwzAQtRBIlMKBP_CVQ1ovWblVXSiogkPLOXLsSWuUxJVtqHpDfAHfyJdgCFdGI82i995oHkLXlIxoiLHyuxFN0pSfoAFNWBHlhBanoedFGhFWpOfowrkXQigrOB2gjwmWwgE2NXa687rRrai-3j91p14lKLx-WI8388fbGdhWeNOYrZZYqDewgWRBSK9N57BwzkgtfGActN_hvTVbK9o2zBKaBisQ_daD7oI8xbrb6Up7Y90lOqtF4-Dqrw7R82K-mS6j1dPd_XSyiiRLCx7RWALwnNRZnuR5xkScVDFUjCVK8KzO4iocScLPFaWK85RTEpJmkPGYCB7zIbrpdaU1zlmoy70N39pjSUn5Y14ZzCt_zQvYcY896AaO_wPL2WbZM74BYNN0BA</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Huang, Ying</creator><creator>Zhu, Lin</creator><creator>Ma, Xiaoying</creator><creator>Hong, Yiyong</creator><creator>Su, Xiangyang</creator><creator>Lai, Wei</creator><creator>Gong, Zijian</creator><general>John Wiley &amp; Sons, Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202209</creationdate><title>A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors</title><author>Huang, Ying ; Zhu, Lin ; Ma, Xiaoying ; Hong, Yiyong ; Su, Xiangyang ; Lai, Wei ; Gong, Zijian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2693-14cee380f7858872a45b4eb225da37f74bdea5152b11d33631031017e7340a343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><creatorcontrib>Ma, Xiaoying</creatorcontrib><creatorcontrib>Hong, Yiyong</creatorcontrib><creatorcontrib>Su, Xiangyang</creatorcontrib><creatorcontrib>Lai, Wei</creatorcontrib><creatorcontrib>Gong, Zijian</creatorcontrib><collection>CrossRef</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Ying</au><au>Zhu, Lin</au><au>Ma, Xiaoying</au><au>Hong, Yiyong</au><au>Su, Xiangyang</au><au>Lai, Wei</au><au>Gong, Zijian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors</atitle><jtitle>Dermatologic therapy</jtitle><date>2022-09</date><risdate>2022</risdate><volume>35</volume><issue>9</issue><epage>n/a</epage><issn>1396-0296</issn><eissn>1529-8019</eissn><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1111/dth.15663</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1396-0296
ispartof Dermatologic therapy, 2022-09, Vol.35 (9), p.n/a
issn 1396-0296
1529-8019
language eng
recordid cdi_crossref_primary_10_1111_dth_15663
source Wiley Online Library All Journals
title A case of sintilimab‐induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A30%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20sintilimab%E2%80%90induced%20SJS/TEN:Dermatologic%20adverse%20reactions%20associated%20with%20programmed%20cell%20death%20protein%E2%80%901%20inhibitors&rft.jtitle=Dermatologic%20therapy&rft.au=Huang,%20Ying&rft.date=2022-09&rft.volume=35&rft.issue=9&rft.epage=n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.15663&rft_dat=%3Cwiley_cross%3EDTH15663%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true